Скачать или смотреть TNXP Stock Has 5x Potential Within 18 Months! |TNXP Stock Technical And Fundamental Analysis

TNXP Stock: Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY. In this TNXP Stock Analysis video, we discuss scalping and investing in the company. We analyze the 50 EMA (Exponential Moving average), MACD (Moving Average Convergence Divergence), RSI (Relative Strength Index), bullish and bearish trends, technical analysis chart patterns, and potential entry and exit points for traders and investors.

TNXP Fundamentals: https://www.marketwatch.com/investing...

TNXP Website: https://www.tonixpharma.com/pipeline/...

TNXP Institutional Shareholders:
https://money.cnn.com/quote/sharehold...

DISCLAIMER: I am not a financial advisor, and my opinions reflect mine only and no other entities. The ideas presented in this video are for entertainment purposes only and not intended as any financial advice, recommendations, suggestions, etc., despite what is stated. You (and only you) are responsible for the financial decisions that you make.

English is not my first language, so please excuse my mistakes. And If you like this video, please hit the like button. It helps me a lot!